32 research outputs found

    Chapter 10 The effect of topography on ash-cloud surge generation and propagation

    Get PDF
    AbstractThe relationship between valley morphology and ash-cloud surge development for 12 pyroclastic density currents (PDCs) at Soufrière Hills Volcano (SHV), Montserrat is investigated. Channel slope, sinuosity and cross-sectional area were measured from high-resolution digital elevation models (DEMs) using geographical information system (GIS) software; and were compared to geometric parameters of the deposits. The data illustrate three surge-generation regimes: a proximal area of rapid expansion; a medial deflation zone; and a steadier distal surge ‘fringe'. The extent to which these regimes develop varies with flow volume. For larger flows, within the proximal and medial regimes, a strong inverse correlation exists between surge detachment and valley cross-sectional area. Surge detachment is also correlated with observed and modelled flow velocities. Areas of topography-induced increases in velocity are interpreted to result in more pervasive fragmentation and fluidization, and thus enhanced surge generation. Distally, surge deposits appear as fringes with decaying extents, indicative of more passive expansion and decreasing velocity. The results indicate that surge mobility and detachment are a complex product of flow mass flux and topography, and that future efforts to model dense–dilute coupled flows will need to account for and integrate several mechanisms acting on different parts of the flow.</jats:p

    Rapid pre-explosion increase in dome extrusion rate at La Soufrière, St. Vincent quantified from synthetic aperture radar backscatter

    Get PDF
    The extrusion rate of a lava dome is a critical parameter for monitoring silicic eruptions and forecasting their development. Satellite radar backscatter can provide unique information about dome growth during a volcanic eruption when other datasets (e.g., optical, thermal, ground-based measurements, etc.) may be limited. Here, we present an approach for estimating volcanic topography from individual backscatter images. Using data from multiple SAR sensors we apply the method to the dome growth during the 2021 eruption at La Soufrière, St. Vincent. We measure an average extrusion rate of 1.8 m³s¯¹ between December 2020 and March 2021 before an acceleration in extrusion rate to 17.5 m³s¯¹ in the 2 days prior to the explosive eruption on 9 April 2021. We estimate a final dome volume of 19.4 million m³, extrapolated from the SAR sensors, with approximately 15% of the total extruded volume emplaced in the last 2 days. A possible explanation for the acceleration in extrusion rate could be the combined emptying of a conduit and reservoir of older material before the ascent of gas-rich magma in April 2021

    Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020: development of a national resource of patient-level genomics laboratory records

    Get PDF
    Objective To describe national patterns of National Health Service (NHS) analysis of mismatch repair (MMR) genes in England using individual-level data submitted to the National Disease Registration Service (NDRS) by the NHS regional molecular genetics laboratories. Design Laboratories submitted individual-level patient data to NDRS against a prescribed data model, including (1) patient identifiers, (2) test episode data, (3) per-gene results and (4) detected sequence variants. Individualised per-laboratory algorithms were designed and applied in NDRS to extract and map the data to the common data model. Laboratory-level MMR activity audit data from the Clinical Molecular Genetics Society/Association of Clinical Genomic Science were used to assess early years’ missing data. Results Individual-level data from patients undergoing NHS MMR germline genetic testing were submitted from all 13 English laboratories performing MMR analyses, comprising in total 16 722 patients (9649 full-gene, 7073 targeted), with the earliest submission from 2000. The NDRS dataset is estimated to comprise >60% of NHS MMR analyses performed since inception of NHS MMR analysis, with complete national data for full-gene analyses for 2016 onwards. Out of 9649 full-gene tests, 2724 had an abnormal result, approximately 70% of which were (likely) pathogenic. Data linkage to the National Cancer Registry demonstrated colorectal cancer was the most frequent cancer type in which full-gene analysis was performed. Conclusion The NDRS MMR dataset is a unique national pan-laboratory amalgamation of individual-level clinical and genomic patient data with pseudonymised identifiers enabling linkage to other national datasets. This growing resource will enable longitudinal research and can form the basis of a live national genomic disease registry. Data availability statement Data are available upon reasonable request. Data may be obtained from a third party and are not publicly available. All data relevant to the study are included in the article or uploaded as supplementary information. All summary data relevant to the study are included in the article or uploaded as online supplementary information. Individual level data detailed in this study are held within NHS Digital with access available on application

    Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    Get PDF
    BACKGROUND Non-alcoholic steatohepatitis (NASH) is a common type of chronic liver disease that can lead to cirrhosis. Obeticholic acid, a farnesoid X receptor agonist, has been shown to improve the histological features of NASH. Here we report results from a planned interim analysis of an ongoing, phase 3 study of obeticholic acid for NASH. METHODS In this multicentre, randomised, double-blind, placebo-controlled study, adult patients with definite NASH, non-alcoholic fatty liver disease (NAFLD) activity score of at least 4, and fibrosis stages F2-F3, or F1 with at least one accompanying comorbidity, were randomly assigned using an interactive web response system in a 1:1:1 ratio to receive oral placebo, obeticholic acid 10 mg, or obeticholic acid 25 mg daily. Patients were excluded if cirrhosis, other chronic liver disease, elevated alcohol consumption, or confounding conditions were present. The primary endpoints for the month-18 interim analysis were fibrosis improvement (≥1 stage) with no worsening of NASH, or NASH resolution with no worsening of fibrosis, with the study considered successful if either primary endpoint was met. Primary analyses were done by intention to treat, in patients with fibrosis stage F2-F3 who received at least one dose of treatment and reached, or would have reached, the month 18 visit by the prespecified interim analysis cutoff date. The study also evaluated other histological and biochemical markers of NASH and fibrosis, and safety. This study is ongoing, and registered with ClinicalTrials.gov, NCT02548351, and EudraCT, 20150-025601-6. FINDINGS Between Dec 9, 2015, and Oct 26, 2018, 1968 patients with stage F1-F3 fibrosis were enrolled and received at least one dose of study treatment; 931 patients with stage F2-F3 fibrosis were included in the primary analysis (311 in the placebo group, 312 in the obeticholic acid 10 mg group, and 308 in the obeticholic acid 25 mg group). The fibrosis improvement endpoint was achieved by 37 (12%) patients in the placebo group, 55 (18%) in the obeticholic acid 10 mg group (p=0·045), and 71 (23%) in the obeticholic acid 25 mg group (p=0·0002). The NASH resolution endpoint was not met (25 [8%] patients in the placebo group, 35 [11%] in the obeticholic acid 10 mg group [p=0·18], and 36 [12%] in the obeticholic acid 25 mg group [p=0·13]). In the safety population (1968 patients with fibrosis stages F1-F3), the most common adverse event was pruritus (123 [19%] in the placebo group, 183 [28%] in the obeticholic acid 10 mg group, and 336 [51%] in the obeticholic acid 25 mg group); incidence was generally mild to moderate in severity. The overall safety profile was similar to that in previous studies, and incidence of serious adverse events was similar across treatment groups (75 [11%] patients in the placebo group, 72 [11%] in the obeticholic acid 10 mg group, and 93 [14%] in the obeticholic acid 25 mg group). INTERPRETATION Obeticholic acid 25 mg significantly improved fibrosis and key components of NASH disease activity among patients with NASH. The results from this planned interim analysis show clinically significant histological improvement that is reasonably likely to predict clinical benefit. This study is ongoing to assess clinical outcomes. FUNDING Intercept Pharmaceuticals

    An inclined Vulcanian explosion and associated products

    No full text
    Vulcanian explosions generate some of the most hazardous types of volcanic phenomena, including pyroclastic density currents. Non-vertical directionality of an explosion promotes asymmetrical distribution of proximal hazards around the volcano. Although critical, such behaviour is relatively uncommon and has been seldom documented. Here we present, for the first time, evidence both from geophysical monitoring and field survey data that records the occurrence of such an event. Thermal imagery captures a Vulcanian explosion at Soufrière Hills Volcano, Montserrat, which occurred during a large partial lava dome collapse in February 2010, and was inclined at about 25° from the vertical in a northerly direction. Pyroclastic products were preferentially distributed to the north and included: an unusual pumice boulder deposit that we propose was formed by a dilute pyroclastic density current; pumice flow deposits; and a proximal lapilli and block fallout lobe. The inclined nature of the explosion is attributed to the asymmetric geometry around the vent. The explosion-derived pyroclastic density currents had notably lower velocities than those associated with lateral blasts, which, we suggest, result from a separate and distinct mechanism. These inclined explosions present an additional mechanism that is able to generate directed pyroclastic density currents, with consequent implications for hazard assessment

    Numerical Simulations of Block-and-Ash Flows Using the Titan2D Flow Model: Examples from the 2006 Eruption of Merapi Volcano, Java, Indonesia

    No full text
    We present Titan2D simulations of two well-characterized block-and-ash flow (BAF) events of the 2006 eruption of Merapi (Java, Indonesia) that affected the Gendol valley on the volcano’s southern flank and adjacent, densely populated interfluve (non-valley) areas: (1) a single dome-collapse event to the south that generated one of the smaller, post-June 14 flows and (2) a sustained, multiple dome-collapse event, also directed to the south, that produced the largest flows of the 2006 eruption emplaced in the afternoon of June 14. Using spatially varying bed friction angles, Titan2D is capable of reproducing the paths, velocities, runout distance, areas covered and deposited volumes of these flows over highly complex topography. The model results provide the basis for estimating the areas and levels of hazards associated with BAFs generated during relatively short as well as prolonged dome-collapse periods and guidance during future eruptive crises at Merapi
    corecore